Brown v. Corteva, Inc.

CourtDistrict Court, E.D. North Carolina
DecidedSeptember 18, 2024
Docket7:23-cv-01409
StatusUnknown

This text of Brown v. Corteva, Inc. (Brown v. Corteva, Inc.) is published on Counsel Stack Legal Research, covering District Court, E.D. North Carolina primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Brown v. Corteva, Inc., (E.D.N.C. 2024).

Opinion

IN THE UNITED STATES DISTRICT COURT FOR THE EASTERN DISTRICT OF NORTH CAROLINA SOUTHERN DIVISION No. 7:23-CV-1409-D

BEVERLY BROWN, et al., )

. Plaintiffs, v. ORDER CORTEVA, INC., et al., □ Defendants.

On October 6, 2023, Beverly Brown (“Brown”), Kenneth Engel (“Engel”), Shirley McNatt (“McNatt”), and Robert Richards (“Richards”) (collectively, “plaintiffs”) filed a complaint against Corteva, Inc. (“Corteva”), DuPont de Nemours, Inc. (“DuPont”), EIDP, Inc. (“EIDP”), the Chemours Company (“Chemours”), and the Chemours Company FC, LLC (“Chemours FC”) (collectively, “defendants”) [D.E. 1]. On December 5, 2023, defendants moved to dismiss plaintiffs’ complaint for failure to state a claim [D.E. 19] and filed a memorandum in support [D.E. 20]. See Fed. R. Civ. P. 12(b)(6). On December 13, 2023, plaintiffs amended their complaint [D.E. 21]. Plaintiffs allege: (1) negligence, (2) gross negligence, (3) negligence per se, (4) public nuisance, (5) private nuisance, (6) trespass to real property, (7) trespass to chattel, and (8) unfair and deceptive trade practices (“UDTPA”). See [D.E. 21] ff 83-120. On December 27, 2023, defendants moved to dismiss plaintiffs’ amended complaint for failure to state a claim [D.E. 22] and filed a memorandum in support [D.E. 23]. See Fed. R. Civ. P. 12(b)(6). On August 2, 2024, plaintiffs responded in opposition [D.E. 36]. On August 16, 2023, defendants replied [D.E. 37]. As explained below, the court grants defendants’ motion to dismiss in part and denies it in part.

Plaintiffs’ negligence, gross negligence, private nuisance, and trespass to real property claims survive.

. I. In 1985, McNatt became a resident of Cumberland County. See Am. Compl. [D.E. □□□ 77. McNatt has a residence connected to a private well. See id. In 1992, Brown became a resident of New Hanover County. See id. at { 71. Brown has a residence connected to the public water system. See id. In 2002, Engel became a resident of New Hanover County. See id. at 74. Engel has a residence connected to the public water system. See id. In 2005, Richards became a resident of Pender County. See id. at { 80. Richards has a residence connected to a private well. See id. Plaintiffs allege as a result of defendants’ actions: (1) McNatt developed breast cancer and thyroid disease, (2) Brown developed colon cancer and Graves’ disease, (3) and Engel and Richards developed prostate cancer. See id. at 73, 76, 79, 82. The Fayetteville Works Plant is located in Bladen County, North Carolina. See id. at q 28. The Fayetteville Works Plant manufactures films, fibers, and specialty chemicals in five discrete manufacturing areas including fluromonomers/nafion, polymer processing aid (“PPA”), butacite, SentryGlas, and polyvinvyl fluoride (“PVF”). See id. at 30. Since the 1980s, defendants have used PFAS at the Fayetteville Works Plant. See id. at J 33-34. A drainage channel used at the outfall area exists from the Fayetteville Works Plant to the Cape Fear River. See id. This segment of the Cape Fear River constitutes surface water, “making it a source of water supply for drinking, culinary, or food processing purposes[,] as well as for aquatic life propagation and maintenance of biological integrity (including fishing and fish), wildlife, secondary recreation, and agriculture.” Id. at ]29. The wastewater from the Fayetteville Works Plant flows from the outfall area through wastewater treatment plants. See id. at | 30. The

wastewater treatment plant dilutes the water with hundreds of thousands of gallons of Cape Fear River water and then discharges the diluted chemicals into the Cape Fear River. See id. While the dilution makes it harder to detect the chemicals, it does not reduce the contaminants flowing into the river. See id. Additionally, the Fayetteville Works Plant has one stack that releases airborne emissions of perfluoroalkyl, which results in additional water contamination of the Cape Fear River. See id. at { 31. Scientists have linked exposure to polyfluoroalky! substances (“PFAS”) to kidney cancer, testicular cancer, prostate cancer, ovarian cancer, non-Hodgkin’s lymphoma, liver disease, ulcerative colitis, thyroid disease, hypercholesterolemia, and pregnancy-induced hypertension. See id. at PFAS remain in the environment, particularly in water, for years. See id. at { 39. Defendants use Nacion byproducts 1 and 2 in their manufacturing process. See id. at { 33. Additionally, in the early 2000s, following pressure from government regulators, defendants replaced perfluorooctanoic acid (“PFOA”) with hexafluoropropylene oxide dimer acid (“GenX”) in its manufacturing process for safety reasons. See id. at | 33. Defendants used GenX, despite animal studies dating back to 1963 that demonstrated an association between GenX and various negative health impacts on laboratory animals. See id. at ] 35. These animal studies indicate that GenX may be as toxic or more toxic than PFOA and could result in adverse effects in humans inciuding reproductive effects, developmental effects, liver effects, immune system disruption, stomach, ocular, and tongue toxicity, and cancer. See id. at 1 36. Even with this knowledge, defendants continued to discharge GenX into the Cape Fear River. See id. at] 37. GenX remains in humans’ bloodstream longer than other PFAS, requiring testing other biomarkers to determine GenX exposure over time. See id. at { 39.

.

In November 2016, North Carolina State University researchers published a study identifying GenX and other PFAS in the Cape Fear River’s water at King’s Bluff from June 14, 2013, to December 2, 2013. See id. at 40-42. GenX levels reached 4,500 parts per trillion and averaged at 631 parts on trillion, exceeding the state’s safety standard of 140 parts per trillion. See id. at J 40. On June 19, 2017, environmental regulators found GenX in quantities exceeding the state’s safety standard at four wastewater treatment plants at Bladen Bluffs, NW Brunswick, Pender County, and CFPU Sweeney. See id. at § 43. On June 20, 2017, Chemours announced it would capture, remove, and safely dispose of the contaminated wastewater. See id. Nonetheless, “[v]Jery

recent testing” shows that plants and vegetables near the Fayetteville Works Plant remain contaminated, meaning that residents potentially consumed PFAS discharged from the Fayetteville Works Plant. Id. at J 44. . In November 2018, North Carolina State University researchers tested Fayetteville Works Plant neighboring residents’ blood and discovered that 99% of participants tested positive for Nafion byproduct 2, reflecting more PFAS in their blood than individuals in other locations. See id. at] 45. On February 25, 2019, Chemours and North Carolina entered a consent order requiring Chemours to remediate its discharge of PFAS. See id. at J] 46-48. Nonetheless, it is “exceedingly difficult . . . if not impossible” to remove PFAS from pipes, fittings, and fixtures. Id. at 7 50-53. Additionally, defendants have attempted to shield assets from creditors and victims. See id. at 7 54-69. On June 15, 2022, the EPA released new advisory drinking water levels capping GenX at 10 parts per trillion. See id. at J 49. “These new health advisories are ‘non-enforceable and non- regulatory’ and ‘provide technical information to states agencies and other public health officials

on health effects, analytical methods, and treatment technologies associated with drinking water contamination.’” Id. tL - A motion to dismiss under Rule 12(b)(6) tests the complaint’s legal and factual sufficiency. See Ashcroft v. Iqbal, 556 U.S. 662, 677-80 (2009); Bell Atl. Corp. v.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Day & Zimmermann, Inc. v. Challoner
423 U.S. 3 (Supreme Court, 1975)
Hicks Ex Rel. Feiock v. Feiock
485 U.S. 624 (Supreme Court, 1988)
Tellabs, Inc. v. Makor Issues & Rights, Ltd.
551 U.S. 308 (Supreme Court, 2007)
Bell Atlantic Corp. v. Twombly
550 U.S. 544 (Supreme Court, 2007)
Ashcroft v. Iqbal
556 U.S. 662 (Supreme Court, 2009)
Coleman v. Maryland Court of Appeals
626 F.3d 187 (Fourth Circuit, 2010)
Rhodes v. EI Du Pont De Nemours and Co.
636 F.3d 88 (Fourth Circuit, 2011)
Coleman v. Court of Appeals of Maryland
132 S. Ct. 1327 (Supreme Court, 2012)
Albert Clatterbuck v. City of Charlottesville
708 F.3d 549 (Fourth Circuit, 2013)
Giarratano v. Johnson
521 F.3d 298 (Fourth Circuit, 2008)
Philips v. Pitt County Memorial Hospital
572 F.3d 176 (Fourth Circuit, 2009)
Town of Nags Head v. Matthew Toloczko
728 F.3d 391 (Fourth Circuit, 2013)
Hawkins v. Hawkins
400 S.E.2d 472 (Court of Appeals of North Carolina, 1991)
Rainey v. St. Lawrence Homes, Inc.
621 S.E.2d 217 (Court of Appeals of North Carolina, 2005)
Keziah v. Seaboard Air Line Railroad Company
158 S.E.2d 539 (Supreme Court of North Carolina, 1968)

Cite This Page — Counsel Stack

Bluebook (online)
Brown v. Corteva, Inc., Counsel Stack Legal Research, https://law.counselstack.com/opinion/brown-v-corteva-inc-nced-2024.